Chronic granulomatous disease. Expression of the metabolic defect by in vitro culture of bone marrow progenitors.
暂无分享,去创建一个
[1] P. Newburger,et al. Dissociation of opsonized particle phagocytosis and respiratory burst activity in an Epstein-Barr virus-infected myeloid cell line , 1980, The Journal of cell biology.
[2] P. Newburger,et al. Activity and activation of the granulocyte superoxide-generating system. , 1980, Blood.
[3] B. Zakhireh,et al. Development of Oxidase activity by human bone marrow granulocytes. , 1979, Blood.
[4] P. Newburger,et al. Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation , 1979, The Journal of cell biology.
[5] B. Andersen,et al. Defective initiation of oxidative metabolism in polymorphonuclear leukocytes. , 1979, New England Journal of Medicine.
[6] J. White,et al. An improved nitroblue tetrazolium test using phorbol myristate acetate-coated coverslips. , 1979, American journal of clinical pathology.
[7] J. Allen,et al. Autooxidation as a basis for altered function by polymorphonuclear leukocytes. , 1977, Blood.
[8] A. Goldman,et al. Undetected carrier state in chronic granulomatous disease. , 1972, The Journal of pediatrics.
[9] G. Hodgson,et al. The Growth of Bone Marrow Cells in Liquid Culture , 1972, British journal of haematology.
[10] T. Stossel,et al. Phagocytosis in chronic granulomatous disease and the Chediak-Higashi syndrome. , 1972, The New England journal of medicine.
[11] B. Pike,et al. Human bone marrow colony growth in agar‐gel , 1970, Journal of cellular physiology.
[12] D. Nathan,et al. Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease. , 1969, The Journal of clinical investigation.